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A coronavirus (SARS-CoV-2) has caused a global pandemic and associated 
morbidity and mortality resultant from COVID-19. As a result of efforts to 
control direct (person to person) and indirect (contaminated objects, surfac-
es, indoor air) transmission of the virus, various interventions have been 
evaluated. Studies were conducted to evaluate the efficacy of commercially 
available chlorine dioxide (CD) products to reduce viral loads on PPE (face 
masks) and surfaces using a novel dry gas release intervention. The efficacy of 
CD slow release 30-day sachets was tested on N95 face masks inoculated with 
human coronavirus OC43 in suspension. One sachet was placed with an in-
oculated mask in plastic resealable bags. Three trials were completed using 
the original sachet where a mask and sachet were placed into a plastic bag for 
13 hours per sachet age of 1 day, 14 days, and 30 days. The amount of CD 
generated during a 13-hour treatment period was 0.30 mg. The nominal con-
centration of CD was estimated to be 317 mg/m3. All three tests demonstrated 
at least a 99.91% reduction of viral loading in the mask versus a non-treated 
control. Efficacy of CD dry gas fast releasing pods (Ultrashok) for fumigation 
was also tested in a 1344 ft3 closed room. Two pods were placed in the space 
and CD surface virucidal efficacy was tested in three locations of the room af-
ter 1 hour and 2 hours of dwell time. The estimated nominal peak concentra-
tion was 15 ppmv in the room. The one-hour exposure saw a >99.91% OC43 
reduction on surfaces and the two-hour exposure resulted in a >99.997% OC43 
reduction on surfaces versus a non-treated control. These results indicate dry 
CD is highly effective against human coronavirus. CD was 99.91% effective 
for eliminating human coronavirus OC43 in both sachet and capsule fumi-
gant form using both fast and slow release mechanisms. Rapid fumigant ap-
plication is suitable for contaminated rooms, ambulances, emergency ve-
hicles, and many types of PPE, most particularly porous PPE materials. The 
gaseous state of CD allows for rapid diffusion and transfer of the virucidal 
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stable free radical to all surfaces of PPE and indoor areas that would favor vi-
rus survival. Additionally, this work suggests CD can be effective at levels 
with significant margins of safety (little to no exposure and rapid degradation 




Chlorine Dioxide Gas, Coronavirus, Virucidal Activity 
 
1. Introduction 
Chlorine dioxide is currently approved by the United States Food and Drug 
Administration (FDA) and Environmental Protection Agency (EPA) for many 
antimicrobial uses, including water purification and food decontamination, thus 
increasing the shelf life of fruit, vegetables, and meat [1] [2]. CD is not a natu-
rally occurring compound and is a gas at room temperature with a boiling point 
of 11°C. Studies of human inhalation that were above the allowable concentra-
tion guideline have resulted in conjunctiva irritation, with no cerebral effects, 
and no carcinogenicity. The Occupational Safety and Health Administration 
(OSHA) and EPA both have the allowable time-weighted average exposure at 0.1 
ppm, with OSHA increasing the concentration to 0.3 ppm for the short-term 
exposure limit. A study published by Akamatsu et al. in 2012 [3] found that rats 
exposed to 0.1 ppm for 24 hours per day and 7 days per week for 6 months did 
not show CD gas-related toxicity, further demonstrating its safety. 
December of 2019 saw the rise of a novel coronavirus (COVID-19) and has 
since grown into a global pandemic. As a result, the United States has seen 
shortages of personal protective equipment (PPE), leading to unnecessarily in-
creased risk for people caring for COVID-19 positive patients like hospital 
workers and emergency medical technicians. CD’s virucidal properties, lack of 
residue, and safety make it ideal for reusing various PPE such as N95 masks. 
This would also be applicable on a bigger scale when applied to surfaces in 
rooms that have been contaminated with the virus. Relatively short fumigation 
of enclosed spaces would allow for fast sterilization with less manual labor re-
quired of the cleaning staff. 
Currently, liquid antimicrobial solutions like hydrogen peroxide and phenols 
are used to manually disinfect various spaces such as operating rooms and am-
bulances. CD’s gaseous state allows it to reach and disinfect even the smallest 
crevices that may otherwise be ignored. CD is commercially sold across the 
country. One such company called ICA Tri-Nova, LLC produces delayed-release 
CD products that range from 1 hour to 30 days, to be used for water purifica-
tion, odor reduction, and more. One of its products is the StayFresh UltraShok, 
which is a small pod that quickly releases CD gas for up to 1 hour. The purpose 
of this study was to evaluate the virucidal efficacy of this product for reducing 
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coronavirus contaminated facemasks and surfaces. 
2. Methods 
2.1. CD Sachet Use on N95 Facemasks 
The test material was contained in a sachet shown in Figure 1. The materials 
consisted of a slow releasing chlorine dioxide reagent each in a clear sealing PE 
plastic bag. The study was performed to evaluate the virucidal efficacy against 
human coronavirus OC43 on inoculated facemasks. The study protocol was an 
adaptation from ASTM E1053 [4]. Briefly, one hundred microliters of virus sus-
pension were added to each of marked sections on three N95 facemasks. The 
inoculation was added as a thin layer. Once inoculated, each of 2 masks was 
placed in a sealed humidified plastic nylon clean bag with a chlorine dioxide sa-
chet. One mask was added to each of the bags. The third facemask was added to 
a humidified bag not containing the slow release sachet. This served as the re-
covery control. A NIST traceable laboratory timer was started. Following over-
night contact time (14 ± 1 hours), each of the facemasks was removed from the 
respective bags and the marked sections were aseptically cut. The sections were 
each added to sterile containers with 10 mL of D/E Neutralizing Broth (Crite-
rion) and were homogenized. The samples were analyzed on the day of collec-
tion at undiluted and at ten-fold dilutions in replicates of 5 for viable infectious 
coronavirus. The entire study was repeated again following 2 weeks using the 
same bags and sachets and again following 30 days after start of exposure. Posi-
tive, negative and neutralization controls were used to provide quality control 
and reference data as per laboratory standard accredited ISO17025:2017 metho-
dology. 
2.2. CD Canister Use on Room Surfaces 
Surface virucidal efficacy was tested using plastic capsules shown in Figure 2 
containing a powder that required activation to release chlorine dioxide gas. The 
study was performed to evaluate virucidal efficacy against human Coronavirus 
OC43 on inoculated carriers placed at random locations within an enclosed  
 
 
Figure 1. CD sachet. 
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Figure 2. CD canister. 
 
room. The size of the room was 1344 ft3 (approximately 7' × 24' × 8'). The study 
was conducted as per laboratory protocol adaptation from ASTM E1053 [4]. 
Briefly, one hundred microliters of virus suspension (containing 5% heat inacti-
vated Fetal Bovine Serum) was added as a thin layer to each 100 mm glass petri 
dish and allowed to dry. The carriers were placed at random locations in the 
room:  
Three carriers were placed at locations open to room air. Two of the capsules 
were placed on the floor in the room and spaced at equal length intervals. The 
temperature of the room was maintained at 19 - 21 degrees C. This resulted in 
low relative humidity (RH). An ultrasonic humidifier was placed into the room 
to maintain humidity at 75% - 85% RH. Additionally, a small 510 CFM fan was 
also placed in the room to allow air circulation and homogeneity of conditions 
in the room. The capsules were activated and immediately the room was vacated 
and sealed. The room was allowed a dwell time of 1 and 2 hours. 
The room was opened, a mild chlorine-based odor was noted but it was not 
overwhelming or irritating. Each of the carriers was removed, immediately add-
ed to sterile containers with 10 mL of D/E Neutralizing Broth, and homoge-
nized. The samples were analyzed for viable infectious coronavirus OC43 on the 
day of the study at undiluted and at ten-fold dilutions in replicates of five. Addi-
tionally, two control glass carriers were inoculated as above but maintained in a 
separate area not exposed to the gas. They were processed similarly following 
recovery of treatment carriers. These served as recovery controls. The number of 
microorganisms recovered from the controls was used to calculate the starting 
concentration. Positive, negative and neutralization controls were included with 
test materials to provide quality control and reference data as per laboratory 
standard accredited ISO17025:2017 methodology [5]. 
Viable virus was analyzed using HRT-18G cell infectivity assay. Cell mono-
layers were monitored for cytopathic effect development over a 14-day period. 
Viruses were enumerated as Infectious Units (I.U.) using the Most Probably 
Number (MPN) analysis of the cell culture results. Analysis was conducted as 
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per method EPA/600/R-95/178 [6] and reported as I.U./Carrier section. All 
equipment and supplies were validated to or were calibrated to NIST traceable 
standards. All QC were within method acceptance limit. No general environ-
mental conditions are specified in the standard or have been identified that 
could affect the test results or measurements. 
3. Results and Discussion 
Gas releasing sachets effectively decontaminated N95 facemasks. Facemasks 
contaminated with human coronavirus OC43 and exposed to chlorine dioxide 
gas for 13 hours were decontaminated with a 99.9% reduction of the virus in the 
facemasks, shown in Figure 3. Infectious virus was not detected in the facemask 
samples analyzed. Similar results were observed following a 14-day and 30-day 
re-challenge, shown in Figure 4 and Figure 5, respectively. 
Gas releasing plastic capsules effectively eliminated virus contaminated sur-
faces. Surfaces contaminated with virus were placed at various locations in an 
enclosed room and subsequently exposed to chlorine dioxide gas. Chlorine dio-
xide gas exposure eliminated 99.99% of the surface virus. Infectious virus was 
not detected on contaminated surfaces at 1 and 2 hours following chlorine dio-
xide fumigation in Figure 6 and Figure 7, respectively. 
Chlorine dioxide was greater than 99.9% effective at eliminating human co-
ronavirus OC43 contamination in facemasks and on room surfaces. 
 
 
Figure 3. Facemask contaminated with coronavirus OC43. 13-hour contact with CD. 
 
 
Figure 4. Facemask contaminated with coronavirus OC43. 13-hr 14-day re-challenge. 
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Figure 5. Facemask contaminated with coronavirus OC43. 13-hr 30-day re-challenge. 
 
 
Figure 6. Room surfaces contaminated with human coronavirus OC43. 1-hour contact 
with chlorine dioxide. 
 
 
Figure 7. Room surfaces contaminated with human coronavirus OC43. 2-hour contact 
with chlorine dioxide. 
4. Conclusion 
Chlorine dioxide gas was reported as effective at preventing aerosol-induced in-
fluenza virus infection [7]. Gas releasing sachets effectively decontaminated N95 
facemasks. Gas releasing plastic capsules effectively eliminated virus contami-
nated surfaces. Chlorine dioxide was greater than 99.9% effective at eliminating 
human coronavirus OC43 contamination in facemasks and on room surfaces. 
Rapid fumigant application is suitable for contaminated rooms, ambulances, 
emergency vehicles, and many types of PPE materials. This work demonstrates 
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chlorine dioxide gas can be effective at levels with significant margins of safety 
(little to no exposure and rapid degradation of residuals) providing minimal 
public health risks associated with the use of chlorine dioxide gas.  
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